Literature DB >> 15893685

Exercise and rehabilitation for individuals with multiple sclerosis.

Theodore R Brown1, George H Kraft.   

Abstract

It is the coexistence of physical and cognitive impairments, together with emotional and social issues in a disease with an uncertain course, that makes MS rehabilitation unique and challenging. Inpatient rehabilitation improves functional independence but has only limited success improving the level of neurologic impairment. Benefits are usually not long lasting. Severely disabled people derive equal or more benefit than those who are less disabled, but cognitive problems and ataxia tend to be refractory. There is now good evidence that exercise can improve fitness and function for those with mild MS and helps to maintain function for those with moderate to severe disability. Therapy can be performed over 6 to 15 weeks in outpatient or home-based settings or as a weekly day program lasting several months. Several different forms of exercise have been investigated. For most individuals, aerobic exercise that incorporates a degree of balance training and socialization is recommended. Time constraints, access, impairment level, personal preferences, motivations, and funding sources influence the prescription for exercise and other components of rehabilitation. Just as immunomodulatory drugs must be taken on a continual basis and be adjusted as the disease progresses, so should rehabilitation be viewed as an ongoing process to maintain and restore maximum function and QOL.

Entities:  

Mesh:

Year:  2005        PMID: 15893685     DOI: 10.1016/j.pmr.2005.01.005

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  20 in total

Review 1.  Complementary and alternative medicine: is there a role in multiple sclerosis?

Authors:  Vijayshree Yadav; Dennis Bourdette
Journal:  Curr Neurol Neurosci Rep       Date:  2006-05       Impact factor: 5.081

Review 2.  Community neurorehabilitation: a synthesis of current evidence and future research directions.

Authors:  Sarah E Chard
Journal:  NeuroRx       Date:  2006-10

3.  Aerobic exercise in people with multiple sclerosis: its feasibility and secondary benefits.

Authors:  Chad Swank; Mary Thompson; Ann Medley
Journal:  Int J MS Care       Date:  2013

4.  Rehabilitation challenges in multiple sclerosis.

Authors:  Jack S Burks; George Kim Bigley; Harry Haydon Hill
Journal:  Ann Indian Acad Neurol       Date:  2009-10       Impact factor: 1.383

5.  Clinician's Commentary on Ploughman et al.(1).

Authors:  Jo-Anne Howe
Journal:  Physiother Can       Date:  2012-01-31       Impact factor: 1.037

6.  Exercise Training Guidelines for Multiple Sclerosis, Stroke, and Parkinson Disease: Rapid Review and Synthesis.

Authors:  Yumi Kim; Byron Lai; Tapan Mehta; Mohanraj Thirumalai; Sangeetha Padalabalanarayanan; James H Rimmer; Robert W Motl
Journal:  Am J Phys Med Rehabil       Date:  2019-07       Impact factor: 2.159

Review 7.  The benefits of exercise training in multiple sclerosis.

Authors:  Robert W Motl; Lara A Pilutti
Journal:  Nat Rev Neurol       Date:  2012-07-24       Impact factor: 42.937

8.  Feasibility and Impact of an 8-Week Integrative Yoga Program in People with Moderate Multiple Sclerosis-Related Disability: A Pilot Study.

Authors:  Evan T Cohen; David Kietrys; Susan Gould Fogerite; Mariella Silva; Kristen Logan; Donald A Barone; J Scott Parrott
Journal:  Int J MS Care       Date:  2017 Jan-Feb

9.  Impact and characteristics of quality of life in Japanese patients with multiple sclerosis.

Authors:  Hiromi Kikuchi; Nobuhiro Mifune; Masaaki Niino; Sadayoshi Ohbu; Jun-ichi Kira; Tatsuo Kohriyama; Kohei Ota; Masami Tanaka; Hirofumi Ochi; Shunya Nakane; Masaji Maezawa; Seiji Kikuchi
Journal:  Qual Life Res       Date:  2010-08-11       Impact factor: 4.147

10.  Use of cognitive aids and other assistive technology by individuals with multiple sclerosis.

Authors:  Kurt L Johnson; Alyssa M Bamer; Kathryn M Yorkston; Dagmar Amtmann
Journal:  Disabil Rehabil Assist Technol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.